[Skip to Content]
[Skip to Content Landing]
Views 673
Citations 0
Viewpoint
Next Generation Neurology
June 2016

Neurologist Comfort in the Use of Next-Generation Sequencing DiagnosticsCurrent State and Future Prospects

Author Affiliations
  • 1Department of Neurology, Children's National Medical Center, Washington, DC
  • 2Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC
  • 3Department of Pediatrics, University of Utah School of Medicine, Salt Lake City
JAMA Neurol. 2016;73(6):621-622. doi:10.1001/jamaneurol.2016.0168

Rare diseases are an increasingly recognized source of health problems worldwide, affecting personal and community health and a creating a substantial financial burden. Although rare individually, rare disorders as a group are common, affecting 350 million people worldwide, and approximately 1 in 10 individuals in the United States.1 Next-generation sequencing (NGS)–based approaches have improved the recognition of rare diseases and facilitated diagnostic yield of their testing.

First Page Preview View Large
First page PDF preview
First page PDF preview
×